Scientific Advisory Board

Robert J. Shmookler Reis, PhD

Professor and Udupa Chair in Geriatrics, Reynolds Institute on Aging
Professor, Univ. of Arkansas for Medical Sciences
Senior Research Career Scientist, Central Arkansas Veterans Healthcare System

Dr. Reis is a pioneer of longevity genetics and age-associated diseases. He developed methods for QTL mapping to identify and characterize genes that govern lifespan in C. elegans. His group was the first to define genetic loci that modulate longevity, Darwinian fitness, and stress resistance. They have also discovered the role of Pirin gene on the X chromosome as a determinant of post-menopausal bone loss in women, and pioneered studies of homologous recombination (HR) and its roles in the etiology and subsequent progression of myeloma, prostate and breast cancers.
The research in Reis lab is focused on protein aggregation as a unifying feature of many or all age-dependent diseases and on specific aggregate proteins that appear to play functional roles in the formation or clearance of aggregates. Predictions from in silico studies are tested in vivo in models of Alzheimer’s and other human neurodegenerative diseases. Molecular genetics and bioinformatics provide complementary tools to discover, understand and test causal links.

Dobri Kiprov, MD

Chief of the Division of Immunotherapy at California Pacific Medical Center in San Francisco, California
Medical Director of Apheresis Care Group (ACG)

Dr. Kiprov has worked in the field of therapeutic apheresis for more than 25 years and published numerous scientific papers on the subject. He served two terms on the American Society for Apheresis (ASFA) and received the ASFA Presidential Award for his pioneering work and significant contribution to the field of apheresis and the Society.
Dr. Kiprov is one of the first physicians in the United States to complete a formal fellowship program in Clinical Immunology and Immunopathology (Massachusetts General Hospital and Harvard Medical School, sponsored by the NIH). He is also the first physician to take and pass the Hemapheresis Practitioner Exam (ASCP).
With his immunology and apheresis background, Dr. Kiprov has been a vital part of the first trials of immunotherapy (cell therapies) and is currently involved in several projects involving cell vaccines and stem cell therapies.

Mark Philip, PhD

PhD from Nottingham Trent University, UK

Mark Philip is an expert in strategy development, product development, business development, fundraising and commercial planning for biotech companies. He has over 25 years of experience of managing businesses, both small and large, primarily in the pharmaceutical, biotechnology, medical device and diagnostics industry. With expertise in strategic planning, operations, product and business development, sales and marketing, Mark has orchestrated multiple turnarounds, built product pipelines, launched new products, sold companies and created significant stakeholder value.

Aubrey De Grey, PhD

Founder and Chief Science Officer of the SENS Research Foundation

Dr. de Grey is one of the most renown gerontologists and public figures in aging. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge. Dr. de Grey is the Editor-in-Chief of Rejuvenation Research, the world highest-impact peer-reviewed journal focused on interventions in aging. He is also a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous other journals and organizations.